Rapid and Automated Fluorescence-Linked Immunosorbent Assay for High-Throughput Screening of Hiv-1 Fusion Inhibitors Targeting gp41
Open Access
- 1 December 2003
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 8 (6) , 685-693
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapyAIDS, 2003
- XTT Formazan Widely Used to Detect Cell Viability Inhibits HIV Type 1 Infection in Vitro by Targeting gp41AIDS Research and Human Retroviruses, 2002
- Structure-Based Identification of Small Molecule Antiviral Compounds Targeted to the gp41 Core Structure of the Human Immunodeficiency Virus Type 1Journal of Medicinal Chemistry, 1999
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- HIV Entry and Its InhibitionCell, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- HIV-1 inhibition by a peptideNature, 1993
- Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.Journal of Experimental Medicine, 1991
- Cellular FITC-linked immunospecific assay (Cell-FLISA) for detection of monoclonal antibodies against cell-surface antigensHuman Immunology, 1986